Drug Database
Back to search

Netherlands· NL-6064d2a5a742

NexoBrid 5 g poeder en gel voor gel

A bromelains product containing bromelaïne, concentraat verrijkt met proteolytische enzymen, registered in Netherlands by MediWound Germany GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC D03BA03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedNexoBrid 5 g poeder en gel voor gelATCD03BA03REGISTER NO.NL-6064d2a5a742PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bromelaïne, concentraat verrijkt met proteolytische enzymenAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bromelains is registered in 11 of 19 countries.

Countries holding a registration under ATC D03BA03 (bromelains), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search bromelains products by name

Bromelains · ATC D03BA03

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BROMELAÏNE, CONCENTRAAT VERRIJKT MET PROTEOLYTISCHE ENZYMEN
Manufacturer
MediWound Germany GmbH
Country
Netherlands (NL)
ATC code
D03BA03
ATC class
Bromelains
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/12/803

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under D03BA03

Bromelains, as other registers publish it.

All bromelains products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ae008212-5e52-4d68-aed7-af17d762db2c
GET /v1/drugs/ae008212-5e52-4d68-aed7-af17d762db2c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gel",
  "route": "Cutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/nexobrid-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Bromelains",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp109109",
  "excipients": [
    "AMMONIUMSULFAAT (E 517)",
    "AZIJNZUUR (E 260)",
    "CARBOMEER 980",
    "DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "BROMELAÏNE, CONCENTRAAT VERRIJKT MET PROTEOLYTISCHE ENZYMEN"
  ],
  "leaflet_url": null,
  "authorised_at": "2012/12/18",
  "procedure_number": "EMEA/H/C/002246",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/12/803",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about bromelains.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console